Listen: J&J’s imminent vaccine data, CRISPR’s confusing boom, and navigating scientific misinformation
When are we getting more Covid-19 vaccine data? Is CRISPR having a dot-com moment? And how to separate disinformation from healthy dissent?
We discuss all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. First, we discuss the implications of Johnson & Johnson’s any-day-now data on a one-shot vaccine for Covid-19. Then, Kevin Davies, executive editor of the CRISPR Journal, joins us to talk about the strange boom in genome editing stocks and the future of the revolutionary technology. Finally, we talk to Megan Ranney, an emergency room physician and Brown University professor, about the challenges of Covid-19 science communication in a post-Trump world.
